4629 — Daishin Chemical Co Balance Sheet
0.000.00%
- ¥6bn
- ¥1bn
- ¥32bn
- 72
- 94
- 59
- 89
Annual balance sheet for Daishin Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 4,472 | 5,159 | 4,585 | 5,706 | 4,861 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10,023 | 9,608 | 12,105 | 11,965 | 12,424 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 15,334 | 15,565 | 17,877 | 18,854 | 18,431 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,138 | 4,137 | 3,987 | 4,090 | 4,142 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 20,607 | 21,033 | 23,256 | 24,393 | 24,133 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 7,139 | 6,599 | 8,379 | 8,714 | 7,916 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 7,649 | 7,042 | 8,744 | 8,951 | 8,110 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 12,958 | 13,991 | 14,512 | 15,442 | 16,022 |
Total Liabilities & Shareholders' Equity | 20,607 | 21,033 | 23,256 | 24,393 | 24,133 |
Total Common Shares Outstanding |